Old Web
English
Sign In
Acemap
>
authorDetail
>
Christine Powell
Christine Powell
Ipsen
Clinical endpoint
Phases of clinical research
Adverse effect
Nuclear medicine
Medicine
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomised, factorial phase II study to determine the optimal dosing regimen for 68 Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.
2021
The Journal of Nuclear Medicine
Irene Virgolini
Shadfar Bahri
Andreas Kjær
Henning Grønbæk
Peter Iversen
Esben Andreas Carlsen
Mathias Loft
Ulrich Knigge
Johanna Maffey-Steffan
Christine Powell
Colin G Miller
Thomas Rohban
Sandy McEwan
Johannes Czernin
Show All
Source
Cite
Save
Citations (2)
A phase II clinical trial to evaluate the optimal activity range and peptide mass dose range of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with GEP-NETs
2020
The Journal of Nuclear Medicine
Irene Virgolini
Shadfar Bahri
Andreas Kjær
Henning Grønbæk
Johannes Czernin
Christine Powell
Colin Miller
Thomas Rohban
Show All
Source
Cite
Save
Citations (0)
1